蔓越莓胶囊在管理前列腺癌患者急性非出血性放射性膀胱炎中不优于安慰剂胶囊:一项III期双盲随机安慰剂对照临床试验
该多中心双盲随机安慰剂对照试验纳入108例前列腺癌放疗患者,101例提供数据集分析(蔓越莓组51例,含甜菜根安慰剂组50例)。结果显示,在更敏感的RICAS量表上,蔓越莓胶囊在日间尿频和膀胱控制方面显著劣于安慰剂;两组膀胱炎严重程度无显著差异。结论认为蔓越莓胶囊不优于含甜菜根安慰剂胶囊。
要点
- 蔓越莓胶囊在日间尿频和膀胱控制方面显著劣于安慰剂(RICAS量表)。
- 蔓越莓组与安慰剂组膀胱炎严重程度无显著差异。
- RICAS量表可能成为未来研究中测量放射性膀胱炎的有用工具。
核心结论
- 在前列腺癌患者队列中,蔓越莓胶囊在管理放射性膀胱炎方面不优于含甜菜根安慰剂胶囊。
研究设计与样本
- 多中心双盲随机安慰剂对照III期临床试验,在新西兰3家医院招募108例前列腺癌患者,101例提供数据集分析(蔓越莓组51例,安慰剂组50例)。
- 患者放疗期间及放疗完成后2周每日早晨服用2粒胶囊。
- 采用改良RTOG、O'Leary间质性膀胱炎量表和新型敏感放射性膀胱炎评估量表(RICAS)评估膀胱炎严重程度,基线及放疗期间每周和放疗后2周评分。
- 放疗方案分层为常规分割或大分割(CHHiP)照射前列腺或前列腺床。
主要发现
- 使用更敏感的RICAS量表,蔓越莓胶囊在日间尿频和膀胱控制方面显著劣于安慰剂胶囊。
- 接受大分割和常规分割照射前列腺的患者之间膀胱炎严重程度无显著差异。
临床怎么用
- 不推荐使用蔓越莓胶囊来管理前列腺癌放疗患者的急性非出血性放射性膀胱炎。
- 可考虑采用RICAS量表在未来研究中评估放射性膀胱炎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Acute radiation cystitis affects the quality of life of many prostate cancer patients. A previous pilot study suggested that cranberry capsules may decrease some of the symptoms of acute radiation cystitis. Here we further test their effectiveness in a multicentre double blinded placebo-controlled clinical trial. MATERIAL AND METHODS: A total of 108 prostate cancer patients were recruited at three New Zealand hospitals between September 2016 and January 2019. Out of this cohort, 101 patients provided datasets for analysis (51 men on cranberry capsules and 50 men on beetroot-containing placebo capsules). Patients took two capsules each morning during RT and for 2 weeks after completion of RT. Three measures were used to assess cystitis severity: modified RTOG, O'Leary interstitial cystitis scale and a sensitive novel radiation induced cystitis assessment scale (RICAS). Cystitis severity was scored at baseline and weekly thereafter during RT and for two weeks after completion of RT. Radiation protocols were stratified to conventional fractionation or hypo-fractionated radiation therapy (CHHiP) to the prostate or radiation to the prostate bed. RESULTS: Cranberry capsules performed significantly worse than placebo capsules with respect to day time frequency and bladder control, using the more sensitive RICAS scale. No significant difference in cystitis severity was seen between patients receiving hypofractionation and those receiving conventional fractionation to the prostate gland. CONCLUSION: Cranberry capsules were not superior to beetroot-containing placebo capsules in managing radiation cystitis in our prostate patient cohort. RICAS may be a useful tool for measuring radiation cystitis in future studies.
引用
- Herst PM, Aumata A, Sword V, et al. Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial. Radiother Oncol. 2020. PMID: 32413530. doi:10.1016/j.radonc.2020.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。